Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01697397Completed

Gastrointestinal Myoelectric Activity Protocol, the G-Tech EEnG Protocol

Role: lead

NCT05298774Not ApplicableCompleted

Myoelectric Activity Following Colorectal Surgery and Return of Bowel Function

Role: collaborator

NCT03774485Completed

Myoelectric GutPrint-Crohn's Disease

Role: collaborator

NCT05712525Unknown

Gut Recovery In Patients Following Surgery

Role: lead

NCT02673671Unknown

G-Tech Feasibility Study for Early Detection of a Post-op Ileus

Role: lead

All 5 trials loaded